|
|
|
|
|
Teisinis statusas
Patentas neįsigaliojo (pagal EPK)
| (51) | INT.CL. | A61K 31/4745 | |
| A61K 31/496 | |||
| A61K 31/513 | |||
| A61K 31/7072 | |||
| A61K 39/395 | |||
| A61K 9/127 | |||
| A61P 35/00 |
| (11) | Patento numeris | 2344161 |
| (13) | Dokumento rūšis | T |
| (96) | Europos patento paraiškos numeris | 09820164.3 |
| Europos patento paraiškos padavimo data | 2009-10-16 | |
| (97) | Europos patento paraiškos paskelbimo data | 2011-07-20 |
| (45) | Paskelbimo apie Europos patento išdavimą data | 2018-12-19 |
| (46) | Apibrėžties vertimo paskelbimo data |
| (86) | Numeris | PCT/CA2009/001483 |
| Data | 2009-10-16 |
| (87) | Numeris | WO 2010/043050 |
| Data | 2010-04-22 |
| (30) | Numeris | Data | Šalis |
| 106109 P | 2008-10-16 | US |
| (72) |
TARDI, Paul, CA
MAYER, Lawrence, CA
BERMUDES, David, US
|
| (73) |
Celator Pharmaceuticals, Inc.,
200 Princeton South Corporate Center, Suite 180, Ewing, NJ 08628,
US
|
| (54) | COMBINATIONS OF A LIPOSOMAL WATER-SOLUBLE CAMPTOTHECIN WITH CETUXIMAB OR BEVACIZUMAB |
| COMBINATIONS OF A LIPOSOMAL WATER-SOLUBLE CAMPTOTHECIN WITH CETUXIMAB OR BEVACIZUMAB |